No Data
No Data
H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21
H.C. Wainwright analyst Joseph Pantginis maintains $PDS Biotechnology(PDSB.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 3
PDS Biotechnology Is Maintained at Buy by B. Riley Securities
PDS Biotechnology Is Maintained at Buy by B. Riley Securities
B.Riley Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $9
B.Riley Financial analyst Mayank Mamtani maintains $PDS Biotechnology(PDSB.US)$ with a buy rating, and adjusts the target price from $11 to $9.According to TipRanks data, the analyst has a success rat
B. Riley Lowers Price Target on PDS Biotechnology to $9 From $11, Maintains Buy Rating
PDS Biotechnology (PDSB) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $5 to $21.
Express News | PDS Biotech Provides Data Update From Ongoing Versatile-002 Phase 2 Clinical Trial in Head and Neck Cancer
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...
No Data